INS and diabetes mellitus: Conversely, we had no cases of AP among liver transplanted individuals who were managing their diabetes with SGLT2 inhibitors, metformin, insulin-based therapies or a combination of these molecules (42, 47, 51 and 38 individuals, respectively).